Revvity | PKI - تكلفة المبيعات





تكلفة المبيعات تغيير تاريخ
Agilent USD 845M 7M 2026-03
Align Technology USD 303.5M 60.47M 2026-03
Bio Techne USD 103.13M 1.47M 2026-03
Bio-Rad Laboratories USD 348M 38.4M 2025-12
Bruker USD 443.6M 84.4M 2026-03
Celltrion KRW 107.42B 295.44B 2025-12
Charles River Laboratories USD 716.51M 5.76M 2026-03
Cspc Pharmaceutical CNY 2.11B 173.58M 2025-12
Danaher USD 2.36B 512M 2026-03
Dentsply International USD 453M 65M 2026-03
Deva Holding AS TRY 991.13M 182.81M 2023-09
Divis Laboratories Ltd INR 12.39B 1.76B 2026-03
Edwards Lifesciences USD 362.6M 19.6M 2026-03
Illumina USD 370M 30M 2026-03
Intuitive Surgical USD 940.3M 21.6M 2026-03
IQVIA Holdings USD 3.08B 161M 2026-03
Kangmei Pharma CNY 841.45M 271.27M 2026-03
Knight Therapeutics CAD 82.22M 1.03M 2025-12
Laboratorios Farma EUR 186.09M 11.06M 2023-12
Laboratory Of America USD 2.6B 4.2M 2026-03
Medical Developments International AUD 7.09M 4.91M 2025-12
Mesa Laboratories USD 21.92M 1.78M 2024-09
Mettler Toledo International USD 410.92M 63.05M 2026-03
Myriad Genetics USD 63M 1.1M 2025-12
Neuren Pharmaceuticals AUD 7.45M 6.56M 2025-06
OraSure Technologies USD 15.43M 113K 2025-12
Organigram Holdings CAD 43.39M 13.54M 2026-03
Pacific Biosciences Of California USD 28.9M 10M 2025-12
Pharma Mar EUR 3.66M 116K 2026-03
Qiagen NV USD 217.43M 29.65M 2025-12
Quest Diagnostics USD 1.99B 57M 2026-03
Quidel USD -79.5M 528.3M 2026-03
Repligen USD 85.97M 8.11M 2026-03
Revvity USD 323.46M 26.93M 2026-03
Sartorius EUR 484.6M 46.6M 2026-03
Sino Biopharmaceutical CNY 3.08B 589.65M 2025-06
Thermo Fisher Scientific USD 6.96B 620M 2026-03
Tilray USD 164.37M 8.41M 2025-09
Waters USD 725M 350.06M 2026-03
Zealand Pharma A/S 410K 5K 2025-06
Zz Pientze Pharmaceu CNY 1.58B 245.15M 2026-03